German CDMO CordenPharma, a specialist in Active Pharmaceutical Ingredients (APIs), excipients, drug products and packaging services (APIs), is investing more than €10...

Private equity investor Astorg has signed a binding agreement with International Chemical Investors Group (ICIG) to acquire Plankstadt, Germany-based CDMO CordenPharma...

Full-service CDMO CordenPharma is making a major investment to increase lipid manufacturing capacity at its CordenPharma Chenôve facility near Dijon, France. The project...

Rumors that German pharmaceutical producer CordenPharma is up for sale have resurfaced following fresh reports that the company’s owner, International Chemical Investors...

German chemical company Wacker and compatriot CDMO CordenPharma have agreed to jointly develop know-how and processes for manufacturing lipid nanoparticles (LNP) to meet...

Contract development and manufacturing organization (CDMO) CordenPharma has announced the completion of a Phase 1 strategic investment to create a Flow Chemistry Centre...

Reacting to recent growth in European domestic demand, Luxembourg-headquartered CordenPharma is expanding capacity for non-GMP peptides at its center of excellence for...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...